• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[癌症辅助化疗:直接成本与长期风险]

[Adjuvant chemotherapy of cancer: immediate costs and long-term risks].

作者信息

Cappelaere P, Demaille A

出版信息

Bull Cancer. 1984;71(4):313-25.

PMID:6498346
Abstract

Medical, psychologic, socio-professional and economic side effects of adjuvant chemotherapy are frequent. Some of these are not easily recognized with accuracy. They influence directly the life of treated patients and perhaps later their medical future. They involve the quality of life for cancer patients, after initial curative treatments. Indications for adjuvant chemotherapy cannot be extended without comparative evaluation of their advantages and disadvantages. It is necessary to select patients with the highest probability of improvement in the duration and the quality of life and to give them so active but the least toxic treatments possible.

摘要

辅助化疗的医学、心理、社会职业和经济副作用很常见。其中一些不容易被准确识别。它们直接影响接受治疗患者的生活,甚至可能影响其未来的医疗状况。它们涉及癌症患者在初始根治性治疗后的生活质量。在没有对辅助化疗的优缺点进行比较评估的情况下,其适应证不能扩大。有必要选择那些生存期和生活质量改善可能性最大的患者,并给予他们积极但毒性最小的治疗。

相似文献

1
[Adjuvant chemotherapy of cancer: immediate costs and long-term risks].[癌症辅助化疗:直接成本与长期风险]
Bull Cancer. 1984;71(4):313-25.
2
Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.他莫昔芬辅助治疗5年后,来曲唑延长辅助治疗对绝经后早期乳腺癌女性的成本效益分析。
Am J Manag Care. 2006 Jul;12(7):374-86.
3
Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.阿那曲唑与他莫昔芬作为早期雌激素受体阳性乳腺癌患者初始辅助治疗的获益及预期成本效益
Cancer. 2004 Sep 15;101(6):1311-22. doi: 10.1002/cncr.20492.
4
[Patients' experience of breast cancer treatment].[乳腺癌治疗的患者体验]
Ugeskr Laeger. 2007 Sep 10;169(37):3114-7.
5
Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence.局部区域复发高危乳腺癌患者乳房切除术后放疗的长期疗效。
Cancer J Sci Am. 1999 Mar-Apr;5(2):77-83.
6
Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.接受或未接受辅助化疗的绝经前淋巴结阴性局部乳腺癌患者的长期生活质量
Br J Cancer. 2000 Sep;83(5):577-82. doi: 10.1054/bjoc.2000.1337.
7
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.一项病例对照研究表明,接受霍奇金淋巴瘤联合治疗方案的患者发生急性白血病的风险显著高于单纯接受化疗的患者,且该风险与放疗范围、化疗类型及疗程相关。
Haematologica. 1998 Sep;83(9):812-23.
8
Adjuvant therapy for breast cancer.乳腺癌辅助治疗
NIH Consens Statement. 2000;17(4):1-35.
9
Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.化疗与卵巢切除作为乳腺癌辅助治疗的对比:一项随机试验中对健康相关生活质量的影响
Breast Cancer Res Treat. 2006 Aug;98(3):275-84. doi: 10.1007/s10549-006-9160-9. Epub 2006 Mar 16.
10
Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.3834例T1-T2期乳腺癌患者保乳手术后辅助治疗的生存情况及乳腺复发情况
Radiother Oncol. 2007 Mar;82(3):287-93. doi: 10.1016/j.radonc.2006.11.009. Epub 2006 Dec 22.